(Q33647275)

28 July 2017

1 reference

title

New directions in treatment research of anorexia and bulimia nervosa (English)

1 reference

28 July 2017

0 references

Kaye W

1

1 reference

28 July 2017

Strober M

series ordinal

2

1 reference

28 July 2017

Stein D

series ordinal

3

1 reference

28 July 2017

Gendall K

series ordinal

4

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

28 July 2017

Biological Psychiatry

1 reference

28 July 2017

45

1 reference

28 July 2017

10

1 reference

28 July 2017

1285-1292

1 reference

Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Does fluoxetine augment the inpatient treatment of anorexia nervosa?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Heritability of binge-eating and broadly defined bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Personality features of women with good outcome from restricting anorexia nervosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Bulimia. Its incidence and clinical importance in patients with anorexia nervosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

A controlled trial of cognitive-behavioural and behavioural treatment of anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

A systematic method for clinical description and classification of personality variants. A proposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Association between 5-HT2A gene promoter polymorphism and anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

The validity of the eating disorder examination and its subscales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

The likelihood of recurrence in bipolar affective disorder: the importance of episode recency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

A controlled study of the effect of therapies aimed at adolescent and family psychopathology in anorexia nervosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

A cognitive behavioural approach to the treatment of bulimia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Risk factors for bulimia nervosa. A community-based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

The heterogeneity of anorexia nervosa. Bulimia as a distinct subgroup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Comparison of cognitive-behavioral and supportive-expressive therapy for bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

A self-rating scale for bulimia. The 'BITE'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Medications in the treatment of eating disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Bingeing behavior and plasma amino acids: a possible involvement of brain serotonin in bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

The genetic epidemiology of bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Comparing the cost effectiveness of psychiatric treatments: bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Treatment of bulimia with antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Bulimia nervosa: an ominous variant of anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

An evaluation of family therapy in anorexia nervosa and bulimia nervosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

5-HT2A promoter polymorphism in anorexia nervosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Modulatory role of serotonin in neural information processing: implications for human psychopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Persistent perfectionism, symmetry, and exactness after long-term recovery from anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Neurobiology of impulsivity and the impulse control disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

The long-term course of severe anorexia nervosa in adolescents: survival analysis of recovery, relapse, and outcome predictors over 10-15 years in a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Eating patterns and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

The night-eating syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Mortality in anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

A pilot study of a randomised trial of cognitive analytical therapy vs educational behavioral therapy for adult anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Long-term outcome of antidepressant treatment for bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Treatment of bulimia with monoamine oxidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

Medication and psychotherapy in the treatment of bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

The Eating Attitudes Test: an index of the symptoms of anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

inferred from DOI database lookup

7 January 2021

based on heuristic

A double-blind controlled trial of lithium carbonate primary anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Cognitive treatments for eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900048-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00048-7

1 reference

28 July 2017

1 reference